IMPLAVAX Trademark

Trademark Overview


On Thursday, September 3, 2020, a trademark application was filed for IMPLAVAX with the United States Patent and Trademark Office. The USPTO has given the IMPLAVAX trademark a serial number of 79296059. The federal status of this trademark filing is REGISTERED as of Tuesday, August 24, 2021. This trademark is owned by Enesi Pharma Limited. The IMPLAVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical drug and vaccine development services, pharmaceutical drug and vaccine delivery system development services, pharmaceutical drug and vaccine development services, scientific research into vaccines and medical and veterinary device and product testing services; consultancy in relation to the aforesaid services, namely, medical and veterinary research and developm...
implavax

General Information


Serial Number79296059
Word MarkIMPLAVAX
Filing DateThursday, September 3, 2020
Status700 - REGISTERED
Status DateTuesday, August 24, 2021
Registration Number6458326
Registration DateTuesday, August 24, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesMedical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical drug and vaccine development services, pharmaceutical drug and vaccine delivery system development services, pharmaceutical drug and vaccine development services, scientific research into vaccines and medical and veterinary device and product testing services; consultancy in relation to the aforesaid services, namely, medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical drug and vaccine development services, pharmaceutical drug and vaccine delivery system development services, pharmaceutical drug and vaccine development services, scientific research into vaccines and medical and veterinary device and product testing services; none of the aforesaid services relating to the treatment of cancer

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnesi Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameEnesi Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameEnesi Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, February 28, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 4, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 3, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 24, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 24, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021ATTORNEY REVIEW COMPLETED
Monday, March 22, 2021LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, January 8, 2021LIMITATION OF GOODS RECEIVED FROM IB
Sunday, December 20, 2020REFUSAL PROCESSED BY IB
Friday, December 11, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, December 1, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 1, 2020REFUSAL PROCESSED BY MPU
Tuesday, November 10, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 9, 2020NON-FINAL ACTION WRITTEN
Monday, November 2, 2020ASSIGNED TO EXAMINER
Friday, October 23, 2020APPLICATION FILING RECEIPT MAILED
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB